Health
Selecting SARS-CoV-2 inhibitors in human airway epithelial cells – News-Medical.Net
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe…
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The vaccination campaign is our current answer against the ongoing spread of SARS-CoV-2 and coronavirus disease (COVID-19) pandemic….
-
Business24 hours agoHow I’d invest in ASX 200 shares if I wanted to sleep well during market volatility
-
Business9 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?
-
General24 hours agoRising temperatures could cause a surge in mental health disorders with young Australians most at risk
-
General22 hours agoClare O’Neil and Michael Sukkar go head-to-head in Q+A election forum in Melbourne